| Literature DB >> 23431499 |
Takuyuki Endo1, Toshimitsu Hamasaki, Ryuhei Okuno, Masaru Yokoe, Harutoshi Fujimura, Kenzo Akazawa, Saburo Sakoda.
Abstract
Parkinsonian rigidity has been thought to be constant through a full range of joint angle. The aim of this study was to perform a detailed investigation of joint angle dependency of rigidity. We first measured muscle tone at the elbow joint in 20 healthy subjects and demonstrated that an angle of approximately 60° of flexion marks the division of two different angle-torque characteristics. Then, we measured muscle tone at the elbow joint in 24 Parkinson's Disease (PD) patients and calculated elastic coefficients in flexion and extension in the ranges of 10°-60° (distal) and 60°-110° (proximal). Rigidity as represented by the elastic coefficient in the distal phase of elbow joint extension was best correlated with the UPDRS rigidity score (r = 0.77). A significant difference between the UPDRS rigidity score 0 group and 1 group was observed in the elastic coefficient in the distal phase of extension (P < 0.0001), whereas no significant difference was observed in the proximal phase of extension and in each phase of flexion. Parkinsonian rigidity shows variable properties depending on the elbow joint angle, and it is clearly detected at the distal phase of elbow extension.Entities:
Year: 2013 PMID: 23431499 PMCID: PMC3568857 DOI: 10.1155/2013/258374
Source DB: PubMed Journal: Parkinsons Dis ISSN: 2042-0080
Patients' clinical details.
| Patient | Age | Gender | Disease | UPDRS score | Medication* | ||
|---|---|---|---|---|---|---|---|
| Part III | Rigidity (R) | Rigidity (L) | |||||
| 1 | 79 | M | 4.5 | 30 | 2 | 1 | C 2 mg; C/L 25/250 mg |
| 2 | 85 | M | 1 | 21 | 1 | 1 | Pra 0.375 mg |
| 3 | 64 | M | 3 | 19 | 1 | 1 | Pra 1.5 mg; C/L 20/200 mg |
| 4 | 50 | F | 5.5 | 15 | 1 | 1 | Per 0.9 mg; B/L 62.5/250 mg; T 1 mg |
| 5 | 58 | F | 20 | 26 | 1 | 1 | B/L 50/200 mg; A 200 mg; T 4.5 mg |
| 6 | 76 | F | 8 | 39 | 2 | 2 | C/L 20/200 mg |
| 7 | 60 | M | 3.5 | 24 | 1 | 1 | Pra 1.375 mg |
| 8 | 77 | F | 4 | 29 | 1 | 1 | Pra 1.5 mg; Per 0.15 mg |
| 9 | 67 | M | 8 | 26 | 1 | 1 | Pra 3 mg; Per 0.9 mg; B/L 75/300 mg; S 2.5 mg |
| 10 | 70 | F | 4.5 | 43 | 1 | 1 | Per 0.75 mg; C/L 20/200 mg |
| 11 | 66 | M | 15 | 45 | 3 | 3 | Per 0.75 mg; B/L 100/400 mg; E 400 mg; S 5 mg; T 4 mg |
| 12 | 73 | F | 12.5 | 32 | 1 | 1 | Pra 1.5 mg; Per 1.05 mg; B/L 75/300 mg; S 5 mg |
| 13 | 58 | M | 9 | 28 | 2 | 3 | Pra 1.5 mg; Per 0.75 mg; C/L 15/150 |
| 14 | 67 | M | 8.5 | 39 | 2 | 1 | Per 0.75 mg; B/L 150/600; S 2.5 mg; T 2 mg |
| 15 | 67 | M | 5 | 53 | 2 | 2 | C 3 mg; C/L 15/150 mg |
| 16 | 78 | M | 5.5 | 35 | 2 | 2 | Pra 3 mg; B/L 75/300 |
| 17 | 47 | M | 9 | 24 | 1 | 2 | Pra 2 mg; C 2 mg; B/L 50/200; A 300 mg |
| 18 | 67 | M | 5.5 | 39 | 1 | 2 | Pra 1.5 mg; Per 0.6 mg; C/L 30/300 |
| 19 | 67 | F | 3 | 45 | 2 | 3 | No medication |
| 20 | 69 | M | 4 | 49 | 4 | 3 | B/L 25/100 |
| 21 | 72 | M | 5 | 49 | 2 | 3 | Pra 1.5 mg; B/L 125/500 |
| 22 | 60 | F | 8 | 18 | 2 | 3 | Pra 2 mg; C 1 mg; C/L 15/150 |
| 23 | 73 | M | 6 | 51 | 4 | 3 | Per 0.15 mg; B/L 62.5/250; A 125 mg; T 2 mg |
| 24 | 65 | F | 2.5 | 29 | 3 | 2 | Pra 0.75 mg; C/L 10/100; S 2.5 mg; D 200 mg |
*C: cabergoline; C/L: carbidopa/levodopa; Pra: pramipexole; Per: pergolide; B/L: benserazide/levodopa; T: trihexyphenidyl; A: amantadin; S: selegiline; E: entacapone; D: droxidopa.
Figure 1Schematic diagram of muscle tone measurement system. This system consists of small 3-axis force sensors, a gyro sensor, and surface electrodes. Two force sensors are placed to sandwich the wrist joint with soft pads to measure the force along the z-axis during flexion and extension movements of the elbow joint and calculate the torque at the elbow joint. The signals from the gyro sensor attached between the force sensors are used to calculate the angle of the elbow joint. The surface electrodes are applied to the muscle belly of the biceps and triceps brachii to record myoelectric activity.
Figure 2Methods of analysis of properties of elbow joint movements for each of the distal and proximal segments with the joint angle of “cutoff point” as their boundary. (a) One regression line was fitted to the data of the 10°–110° portion of the degree-torque characteristics curve obtained during extension of the elbow joint of a normal healthy subject. (b) Two regression lines were fitted to the data of the same subject. The extension of the elbow joint was divided into the proximal phase and distal phase at the angle of the elbow joint of “cutoff point.”
Figure 3Results for elastic coefficients in elbow flexion and extension for each of distal and proximal phase. Comparison between the elastic coefficient in (a) the distal phase of flexion (10–60°), (b) the proximal phase of flexion (60–110°), (c) the distal phase of extension (10–60°), and (d) the proximal phase of extension (60–110°) and the UPDRS rigidity score. The elastic coefficient in the distal phase of extension showed the best correlation (r = 0.77) and demonstrated a significant difference between the UPDRS rigidity score 0 group and 1 group, whereas other three elastic coefficients did not show a significant difference between the groups.